Breast Cancer News
The Living Centre Breast Cancer News Updates... 16th September 2011
Selected articles from The Cancer Council Victoria: Cancer Information & Support Service, Cancer News. Approved for use by editor, Doreen Akkerman A.M
Women's cancers reach two million
14 September 2011 - Two million women were diagnosed with breast or cervical cancer last year, according to global figures. A sharp rise in cases was seen in women under 50 in low-income nations, say US experts. Women in richer countries fared better due in part to screening, medicines, anti-smoking policies and vaccines, they report in the Lancet. The research backs
For Young Breast Cancer Patients, Breast-Conserving Therapy Appears Effective-Two studies find similar survival for women under 40 with a lumpectomy or a mastectomy
Wednesday, September 7, 2011 (Health Day News) -- Younger women with breast cancer who undergo a lumpectomy to remove their tumour survive just as long and aren't any more likely to have a recurrence than women who opt for the more radical and disfiguring mastectomy, or removal of the entire breast, two new studies report. "These results will give young women with breast cancer some reassurance if they choose to have a lumpectomy," said Dr. Julliette Buckley, lead author of one of the studies, at a Tuesday news conference. "They can feel safe and secure in making the choice to keep their breast." The findings, which were presented Tuesday ahead of the 2011 Breast Cancer Symposium in San Francisco, which starts Thursday,relate specifically to women under the age of 40. Because these studies were to be presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study
Journal of Clinical Oncology, 06/10/2009 Grant CS et al. - In a study to examine a trial of menstrual cycle phase and outcome after breast cancer surgery, it was found that when menstrual cycle phases were strictly defined, neither disease-free survival (DFS) nor overall survival (OS) differed between women who underwent surgery during the follicular phase vs. the luteal phase. Nearly 30% of pts did not meet criteria for either follicular- or luteal-phase categories.
MBCS: Newer Bone Drug Questioned Over Cost
September 11, 2011SAN FRANCISCO -- Denosumab (Xgeva) may not be cost- effective for the prevention of skeletal-related events in breast cancer with bone metastasis, researchers cautioned. While denosumab had as low as a 17.3 number needed to treat (NNT) to prevent one skeletal-related event compared with zoledronic acid (Zometa), sensitivity analyses suggested a relative cost of nearly $270,000 to do so, according to an industry-funded study by Jipan Xie, MD, PhD, of the Analysis Group, a consulting firm in Boston, and colleagues. The cost to prevent one pathologic fracture with the antibody versus the bisphosphonate was more than $300,000, the group reported here at the Multidisciplinary Breast Cancer Symposium.
Venlafaxine, Clonidine Reduce Hot Flashes in Breast Cancer
TUESDAY, Sept. 13 (Health Day News) -- Venlafaxine and clonidine effectively manage hot flashes in patients with breast cancer, with hot flash scores reducing more immediately with venlafaxine than clonidine, and reducing more significantly with clonidine during week 12 of treatment than with venlafaxine, according to a study published online Sept. 12 in the Journal of Clinical Oncology.
Mother’s Cancer Shows Up Earlier in Daughters
September 12, 2011Women who are diagnosed with breast and ovarian cancers that are linked to some inherited mutations appear to develop the diseases earlier than the previous generation, researchers reported. More than 100 women with BRCA- related cancer developed disease almost eight years younger than relatives in the previous generation, according to Jennifer Litton, MD, and colleagues at the University of Texas MD Anderson Cancer Centre in Houston. The findings add to the evidence for so-called "anticipation" in breast and ovarian cancer -- a phenomenon in which later generations have earlier onset or more severe disease than their ancestors, Litton and colleagues reported online in Cancer.
Spice up broccoli to fight cancer
13/09/2011- Combining broccoli with spicy foods including mustard, horseradish, or wasabi could enhance its cancer-fighting power, new research has found. A study by the University of Illinois found teaming the vegetable with spicy food containing the enzyme myrosinase also ensures it is absorbed in the upper part of the digestive system for maximum health benefit. The study was published in the British Journal of Nutrition.
If you or someone you love is affected by cancer, call the Cancer Helpline at 13 11 20 or view our website www.cancervic.org.au
If you wish to include an item in the Cancer News or if you wish to unsubscribe to this newsletter-contact Doreen.Akkerman@cancervic.org.au
This newsletter does not reflect the views of the Cancer Council Victoria. It is put together from items in various medical journals and newsletters. If you are interested in an item, we suggest that you Google the resource and find the article on their website.
